Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 22, 1998, Pages 3275-3280

  Kotoris, Christopher C ^a   Chen, Mei Jin ^a   Taylor, Scott D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA,ALPHA DIFLUOROSULFONATE; ALPHA,ALPHA DIFLUOROTETRAZOLE; ORGANOPHOSPHATE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; REACTION ANALYSIS; STRUCTURE ANALYSIS;

BIOSTERES;

EID: 0032542042     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00598-8     Document Type: Article

References (25)

1. 1. For a recent review on PTP's see: Zhang, Z-Y. Crit. Rev. Biochem. Mol. Biol. 1998, 33, 1.
2. 2. Burke, T. R. Drugs of the Future 1992, 17, 119.
3. 3. (a) Burke, T. R.; Kole, H. K.; Roller, P. P. Biochem. Biophys. Res. Commun. 1994, 204, 129.
4. (b) Chen, L.; Wu, L.; Otaka, A.; Smyth, M. S.; Roller, P. R.; Burke, T. R.; den Hertog, J.; Zhang, Z-Y. Biochem. Biophys. Res. Comm. 1995, 276, 976.
5. (c) Kole, K. H.; Smyth, M. S.; Russ, P. L.; Burke, T. R. Biochem. J 1995, 311, 1025.
6. (d) Taylor, S. D.; Kotoris, C. C.; Dinaut, A. N.; Wang, Q.; Ramachandran, C.; Huang, H. Bioorg. Med. Chem. in press,
7. (e) Wang, Q.; Huang, Z.; Ramachandran, C.; Dinaut, A. N. and Taylor, S. D. Bioorg. Med. Chem. Lett. 1998, 8, 345.
8. (f) Burke, T. R.; Ye. B.; Yan, X.; Wang, S.; Jia, Z., Chen, L.; Zhang, Z-Y.; Barford, D. Biochemistry 1996, 35, 15898.
9. 4. (a) Kole, H. K.; Akamatsu, M.; Ye, B.; Yan, X.; Barford, D.; Roller, P. P.; Burke, T. R. Biochem. Biophys. Res. Commun. 1995, 209, 817.
10. (b) Burke, T. R.; Ye, B.; Akamatsu, M.; Ford, H.; Kole, H. K.; Wolf, G.; Shoelson, S. E.; Roller, P. R. J. Med. Chem. 1996, 39, 1021.
11. (c) Akamatsu, M.; Roller, P. R.; Chen, L.; Zhang, Z-Y.; Ye, B.; Burke, T. R. Bioorg. Med. Chem. 1997, 5, 157.
12. 5. Abdellaoui, H.; Depreux, P.; Lesieur, D.; Pfeiffer, B.; Bontempelli, P. Synthetic Commun. 1995, 1303.
13. 6. (a) Taylor, S. D.; Kotoris, C. C.; Dinaut, A. N.; Chen, M-J. Tetrahedron 1998, 54, 1691.
14. (b) Taylor, S. D.; Dinaut, A. N.; Thadani, A. T.; Huang, Z. Tetrahedron Lett. 1996, 37, 8089.
15. 7. A detailed analysis and the scope of this reaction is in progress and will be reported in due course.
16. 8. NFSi has previously been used for preparing α,α,-difluorocarboxylic esters. For example see: Differding, E.; Ruegg, G. M.; Lang, R. W. Tetrahedron Lett. 1991, 32, 1779.
17. 9. Ye, B.; Burke, T. R. Tetrahedron Lett. 1995, 36, 4733.
18. 10. Ledon, H. Synthesis 1974, 347.
19. 11. PTP1B is an intracellular PTP consisting of a single catalytic domain. There is now considerable evidence that this enzyme may be involved in the down-regulation of insulin signaling by dephosphorylating specific phosphotyrosine residues on the insulin receptor kinase. Thus, PTP1B is now being considered as a potential therapeutic target to help combat certain forms of diabetes. See: Bandyopadhyay, D.; Kusari, A.; Kenner, K. A.; Liu, F.; Chernoff, J.; Gustafson, T. A.; Kusari, J. J. Biol. Chem. 1997, 272, 1639 and references therein.
20. 12. (a) Liotta, A. S.; Kole, H. K.; Fales, H. M.; Roth, J.; Bernier, M. J. Biol. Chem. 1994, 269, 22996.
21. (b) Kole, H. K.; Garant, M. J.; Fales, H. M.; Roth, J.; Bernier, M. J. Biol. Chem. 1996, 277, 14302.
22. (c) Desmarais, S.; Jia, Z.; Ramachandran, R. Arch. Biochem. Biophys. 1998, 354, 225.
23. 13. Bettlelheim, F. R. J. Am. Chem. Soc. 1954, 76, 2838.
24. i'S were determined using the procedure outlined in reference 3d
25. 15. Burger, A. Prog. Drug Res. 1991, 37, 287.